The INTS8 antibody has been validated in multiple studies:
| Application | Dilution Range |
|---|---|
| Western Blot (WB) | 1:200–1:1000 |
| Immunoprecipitation (IP) | 0.5–4.0 µg per 1–3 mg lysate |
| Immunofluorescence (IF) | 1:10–1:100 |
Optimization: Titration is critical due to batch-specific variability .
Controls: Use HIBE (normal biliary epithelial) and CHOL cell lines (HCCC-9810, RBE) for comparative studies .
Transcriptional Regulation: INTS8 is a core component of the Integrator complex, essential for snRNA 3'-end processing and transcriptional termination .
Cancer Progression: Drives epithelial-to-mesenchymal transition (EMT) via TGF-β signaling in HCC and CHOL .
Neurodevelopmental Disorders: Mutations in INTS8 destabilize the Integrator complex, impairing neuronal differentiation and mRNA processing .